Challenges of Substance Use Disorders in Iran: A Letter to the Editor

authors:

avatar Mehran Rostami ORCID 1 , * , avatar Shahab Rezaeian ORCID 2

Deputy of Treatment, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
Department of Epidemiology, School of Health, Kermanshah University of Medical Sciences, Kermanshah, IR Iran
International Journal of High Risk Behaviors and Addiction: Vol.8, issue 3; e95534
published online: September 2, 2019
article type: Letter
received: June 20, 2019
revised: July 28, 2019
accepted: July 31, 2019
DOI: https://doi.org/10.5812/ijhrba.95534

how to cite: Rostami M, Rezaeian S. Challenges of Substance Use Disorders in Iran: A Letter to the Editor. Int J High Risk Behav Addict. 2019;8(3):e95534. https://doi.org/10.5812/ijhrba.95534.

Acknowledgements

References

  • 1.

    Karamouzian M, Madani N, Doroudi F, Haghdoost AA. Improving the quality and quantity of HIV data in the Middle East and North Africa: key challenges and ways forward. Int J Health Policy Manag. 2016;6(2):65-9. [PubMed ID: 28812781]. [PubMed Central ID: PMC5287931]. https://doi.org/10.15171/ijhpm.2016.112.

  • 2.

    Ghoreishi SMS, Shahbazi F, Mirtorabi SD, Ghadirzadeh MR, Hashemi Nazari SS. Epidemiological study of mortality rate from alcohol and illicit drug abuse in Iran. J Res Health Sci. 2017;17(4). e00395. [PubMed ID: 29233952].

  • 3.

    Amin-Esmaeili M, Motevalian A, Hajebi A, Sharifi V, Stockwell T, Rahimi-Movaghar A. Methods for calculation of per capita alcohol consumption in a Muslim majority country with a very low drinking level: Findings from the 2011 Iranian mental health survey. Drug Alcohol Rev. 2018;37(7):874-8. [PubMed ID: 30027547]. https://doi.org/10.1111/dar.12847.

  • 4.

    Rostami M, Mohammadi Y, Jalilian A, Nazparvar B. Modeling spatio-temporal variations of substance abuse mortality in Iran using a log-Gaussian Cox point process. Spat Spatiotemporal Epidemiol. 2017;22:15-25. [PubMed ID: 28760264]. https://doi.org/10.1016/j.sste.2017.05.002.

  • 5.

    Rostami M, Karamouzian M, Khosravi A, Rezaeian S. Gender and geographical inequalities in fatal drug overdose in Iran: A province-level study in 2006 and 2011. Spat Spatiotemporal Epidemiol. 2018;25:19-24. [PubMed ID: 29751889]. https://doi.org/10.1016/j.sste.2018.01.001.

  • 6.

    Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016;111(10):1836-47. [PubMed ID: 27177849]. https://doi.org/10.1111/add.13453.

  • 7.

    Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A, Nakhaee M. Prevalence and Cause of Self-Medication in Iran: A Systematic Review and Meta-Analysis Article. Iran J Public Health. 2015;44(12):1580-93. [PubMed ID: 26811809]. [PubMed Central ID: PMC4724731].

  • 8.

    Karamouzian M, Mirzazadeh A, Rawat A, Shokoohi M, Haghdoost AA, Sedaghat A, et al. Injection drug use among female sex workers in Iran: Findings from a nationwide bio-behavioural survey. Int J Drug Policy. 2017;44:86-91. [PubMed ID: 28478309]. https://doi.org/10.1016/j.drugpo.2017.03.011.

  • 9.

    Radfar SR, Nematollahi P, Farhoudian A, Noroozi A. Lead poisoning among opium users in Iran: A possible new emerging epidemic in the region. Iran J Public Health. 2017;46(8):1152-3. [PubMed ID: 28894723]. [PubMed Central ID: PMC5575401].

  • 10.

    Samadi S, Baneshi MR, Haghdoost AA. Pattern of alcohol consumption among men consumers in Kerman, Iran. Addict Health. 2017;9(3):139-45. [PubMed ID: 29657694]. [PubMed Central ID: PMC5894793].